Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 32 Issue 6
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2014  >  32(6): 405-408

BU Xiaolin, BI Xinling, XU Xiaoguang, GAO Zhixiang, LI Hui, GU Jun. The research progress of parathyroid hormone and parathyroid hormone-related peptide in skin disease[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 405-408. doi: 10.3969/j.issn.1006-0111.2014.06.002
Citation: BU Xiaolin, BI Xinling, XU Xiaoguang, GAO Zhixiang, LI Hui, GU Jun. The research progress of parathyroid hormone and parathyroid hormone-related peptide in skin disease[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 405-408. doi: 10.3969/j.issn.1006-0111.2014.06.002
shu

The research progress of parathyroid hormone and parathyroid hormone-related peptide in skin disease

doi: 10.3969/j.issn.1006-0111.2014.06.002
  • 1.

    Department of Dermatology, Shanghai Pudong New Area Gongli Hospital, Shanghai 200135, China;Department of Dermatology, Changhai Hospital affiliated to Secend Military Medical University, Shanghai 200433, China

  • 2.

    Department of Dermatology, Changhai Hospital affiliated to Secend Military Medical University, Shanghai 200433, China

  • Received Date: 2013-06-13
  • Rev Recd Date: 2013-12-02
  • Parathyroid hormone/parathyroid hormone-related peptides are polypeptide hormones. They have similar gene structure and same membrane receptor. They play great roles in regulating the calcium and phosphorus metabolism in vivo. PTH/PTHrP and their receptors are expressed in tissues of tumor,skin, hair follicle and other normal tissues. Because of their physiological action on the proliferation and differentiation of epidermis and hair growth,they may be a potential therapeutic target for some skin diseases including psoriasis.
  • [1] Oquendo M, Abramovits W, Morrell P.Topical vitamin D analogs available to treat psoriasis[J]. Skin Med, 2012,10(6):356-360.
    [2] Shah KN.Diagnosis and treatment of pediatric psoriasis: current and future[J]. Am J Clin Dermatol,2013,14(3):195-213.
    [3] Holick MF. Clinical efficacy of 1,25-dihydroxyvitamin D3 and its analogues in the treatment of psoriasis[J]. Retinoids,1998,14: 12-17.
    [4] Cupp ME, Nayak SK, Adem AS, et al.Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways[J]. J Pharmacol Exp Ther,2013,345(3):404-418.
    [5] Whitfield JF, Isaacs RJ, Chakravarthy B, et al.Stimulation of protein kinase C activity in cells expressing human parathyroid hormone receptors by C-and N-terminally truncated fragments of parathyroid hormone 1-34[J]. J Bone Miner Res, 2001,16(3):441-447.
    [6] Strewler GJ,Nissenson RA.Hypercalcemia in malignancy[J]. West J Med,1990,153(6):635-640.
    [7] Wysolmerski JJ, Broadus AE.Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein[J]. Annu Rev Med, 1994,45:189-200.
    [8] Strewler GJ. The parathyroid hormone-related protein[J]. Endocrinol Metab Clin North Am, 2000,29(3):629-645.
    [9] Milanesi A, Yu R, Wolin EM.Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors: report of six cases[J]. Pancreatology, 2013,13(3):324-326.
    [10] Nilubol N, Weisbrod AB, Weinstein LS,et al.Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy[J]. World J Surg,2013,37(8):1966-1972.
    [11] Hiremath M, Wysolmerski J.Parathyroid hormone-related protein apecifies the mammary mesenchyme and regulates embryonic mammary sevelopment[J]. J Mamm Gland Biol Neopl,2013,18(2):171-177.
    [12] Jia T, Qureshi AR, Brandenburg V,et al.Determinants of dibroblast growth dactor-23 and parathyroid hormone variability in dialysis patients[J]. Am J Nephrol, 2013,37(5):462-471.
    [13] Metzger M, Houillier P, Gauci C, et al.Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold[J].J Clin Endocrinol Metab,2013,98(7):2922-2928.
    [14] Urea P.The PTH/PTHrP receptor: biological implications[J].Nefrologia,2003,23(Suppl 2):12-17.
    [15] Errazahi A, Bouizar Z, Lieberherr M,et al.Functional type I PTH/PTHrP receptor in freshly isolated newborn rat keratinocytes: identification by RT-PCR and immunohistochemistry[J].J Bone Miner Res, 2003,18(4):737-750.
    [16] Calvi LM, Adams GB, Weibrecht KW,et al. Osteoblastic cells regulate the haematopoietic stem cell niche[J].Nature, 2003,425(6960):841-846.
    [17] Weber JM, Adams GB, Guaman ML, et al. Parathyroid treatment improves survival after bone marrow transplantation and increases osteoblastic expression of the Notch ligand Jagged 1[J].J Bone Miner Res,2004,19:S407.
    [18] Aho S.Soluble form of Jagged1: unique product of epithelial keratinocytes and a regulator of keratinocyte differentiation[J].J Cell Biochem, 2004,92(6):1271-1281.
    [19] Holick MF, Nussbaum S, Persons KS. PTH-like humoral hypercalcemia factor (HHF) of malignancy may be an epidermal differentiation factor:synthetic hHHF(1-34) NH2 inhibits proliferation and induces terminal differentiation of cultured human kerationcytes[J].J Bone Miner Res,1988,3:S214.
    [20] Hanafin NM, Chen TC, Heinrich G,et al.Cultured human fibroblasts and not cultured human keratinocytes express a PTH/PTHrP receptor mRNA[J].J Invest Dermatol,1995,105(1):133-137.
    [21] Whitfield JF.Taming psoriatic keratinocytes-PTHs'uses go up another notch[J].J Cell Biochem,2004,93(2):251-256.
    [22] KaiserSM, Sebag M, Rhim JS,et al.Antisense-mediated inhibition of parathyroid hormone-related peptide production in a keratinocyte cell line impedes differentiation[J].Mol Endocrinol,1994,8(2):139-147.
    [23] Juhlin L, Hagforsen E, Juhlin C.Parathyroid hormone related protein is localized in the granular layer of normal skin and in the dermal infiltrates of mycosis fungoides but is absent in psoriatic lesions[J].Acta Derm Venereol,1992,72(2):81-83.
    [24] Whitfield JF, Chakravarthy BR, Durkin JP,et al.Parathyroid hormone stimulates protein kinase C but not adenylate cyclase in mouse epidermal keratinocytes[J].J Cell Physiol, 1992,150(2):299-303.
    [25] Dore RK.Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis[J].Patient Prefer Adher, 2013,7:435-446.
    [26] Horwitz MJ, Augustine M, Kahn L,et al.A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study[J].J Bone Miner Res, 2013,28(11):2266-2276.
    [27] Holick MF, Chimeh FN, Ray S.Topical PTH (1-34) is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trial[J].Br J Dermatol, 2003,149(2):370-376.
    [28] Peters EM, Foitzik K, Paus R,et al.A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist[J].J Invest Dermatol, 2001,117(2):173-178.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(3981) PDF downloads(115) Cited by()

Related
Proportional views

The research progress of parathyroid hormone and parathyroid hormone-related peptide in skin disease

doi: 10.3969/j.issn.1006-0111.2014.06.002
  • 1. Department of Dermatology, Shanghai Pudong New Area Gongli Hospital, Shanghai 200135, China;Department of Dermatology, Changhai Hospital affiliated to Secend Military Medical University, Shanghai 200433, China
  • 2. Department of Dermatology, Changhai Hospital affiliated to Secend Military Medical University, Shanghai 200433, China
  • Received Date: 2013-06-13
  • Rev Recd Date: 2013-12-02

Abstract: Parathyroid hormone/parathyroid hormone-related peptides are polypeptide hormones. They have similar gene structure and same membrane receptor. They play great roles in regulating the calcium and phosphorus metabolism in vivo. PTH/PTHrP and their receptors are expressed in tissues of tumor,skin, hair follicle and other normal tissues. Because of their physiological action on the proliferation and differentiation of epidermis and hair growth,they may be a potential therapeutic target for some skin diseases including psoriasis.

BU Xiaolin, BI Xinling, XU Xiaoguang, GAO Zhixiang, LI Hui, GU Jun. The research progress of parathyroid hormone and parathyroid hormone-related peptide in skin disease[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 405-408. doi: 10.3969/j.issn.1006-0111.2014.06.002
Citation: BU Xiaolin, BI Xinling, XU Xiaoguang, GAO Zhixiang, LI Hui, GU Jun. The research progress of parathyroid hormone and parathyroid hormone-related peptide in skin disease[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 405-408. doi: 10.3969/j.issn.1006-0111.2014.06.002
shu

    HTML

Reference (28)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: [email protected]

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return